Form D — Moonwalk Biosciences, Inc.

0002004362-26-000003 · filed Sep 14, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06b
Reported offering amount: $70,249,973
Reported amount sold: $59,999,998
Minimum investment: $0
Investors: 7
Sales commission: $0
Finders' fees: $0

Issuer

Name: Moonwalk Biosciences, Inc.
CIK: 2004362
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: 2022
Address: 2 TOWER PLACE, 8TH FLOOR
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-540-9709

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Alexander Aravanis · Executive Officer

South San Francisco, CA Find on LinkedIn ↗
Arash Jamshidi · Executive Officer

South San Francisco, CA Find on LinkedIn ↗
Chris Dimitropoulos · Director

South San Francisco, CA Find on LinkedIn ↗
Paul Burton · Director

South San Francisco, CA Find on LinkedIn ↗
Justin Valley · Executive Officer

South San Francisco, CA Find on LinkedIn ↗
Elaine Cheung · Executive Officer

South San Francisco, CA Find on LinkedIn ↗
Stephen Djedjos · Executive Officer

South San Francisco, CA Find on LinkedIn ↗
John Liles · Executive Officer

South San Francisco, CA Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗